National Stroke Foundation

Cipro (ciprofloxacin HCl)

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.


Approval Status:

Approved June 1997

Specific Treatments:

acute sinusitis

General Information

Bayer received approval to market Cipro for acute sinusitis. Cipro’s indications already include the treatment for a wide variety of infectious diseases in adults including lower respiratory infections, urinary tract infections, chronic bacterial prostatis, intra-abdominal infections (with metronidazole), bone and joint infections, and skin and skin structure infections.